By Topic
3 ASX Stocks with Recent Bullish Breakouts
When you track the ASX day after day, you eventually spot those moments when a stock stops drifting and suddenly kicks into gear. A clear breakout, the kind that pushes past weeks of hesitation, often tells you buyers are finally taking control. In this article, we’re looking at three Australian companies whose share prices have recently surged through key resistance levels. These aren’t just quick spikes or one-day wonders. Each chart shows a pattern of tightening ranges, rising volume, and a decisive move that suggests momentum may continue.
Why Adisyn (ASX: AI1) Share Price Is Suddenly One of the Hottest Movers on the ASX
Adisyn (ASX: AI1) has surged into the ASX spotlight after breakthrough graphene chip technology, defence expansion, and strong institutional backing fuelled a massive share price rally, positioning the company as a highly speculative but fast-rising AI semiconductor play.
Elevra Lithium (ASX: ELV) Share Price Just Hit Fresh Highs Amid Lithium Momentum
Elevra Lithium has surged over 400% amid stronger lithium prices, record revenue, and growing EV demand. Backed by North America’s largest hard-rock lithium mine, ELV remains technically bullish, with investors closely watching a breakout above A$14.20.
Can Develop Global (ASX: DVP) Sustain Its Breakout Toward New Highs?
Develop Global (ASX: DVP) is gaining momentum as Woodlawn reaches steady-state production, Sulphur Springs economics improve, and mining services expand. Supported by strong copper and zinc markets, the company’s breakout reflects operational execution, contract growth, and multiple upcoming catalysts.
Why Megaport (ASX: MP1) Shares Just Skyrocketed More Than 35%?
Megaport (ASX: MP1) shares surged over 35% after the company secured AI infrastructure contracts worth A$254 million through Latitude.sh, strengthening its position in the booming AI compute and cloud connectivity market.
Pacific Edge (ASX: PEB): Testing Critical Resistance, Breakout or Reversal Ahead?
Pacific Edge (ASX: PEB) tests critical resistance near 0.240 after surging on draft Medicare coverage, a 75% increase in reimbursement rates, and a NZ$25.4 million capital raise. Strong volume supports the rally, but RSI near 70 warns of potential pullback risk.
...